ReviewCureus2026
Evaluation of Physical Activity and Lifestyle Interventions During and After Chemotherapy for Ovarian Cancer: A Systematic Review of Patient Experiences and Clinical Outcomes.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian cancer is a highly lethal gynecological malignancy, with chemotherapy-associated toxicity leading to fatigue, reduced physical function, and poor quality of life. Physical activity and lifestyle interventions may offer supportive benefits, but evidence in ovarian cancer remains limited and heterogeneous. This study aimed to assess how lifestyle modifications and physical activity during and after chemotherapy affect clinical outcomes and patient-reported experiences in women with ovarian cancer. A systematic review was conducted in accordance with PRISMA standards. PubMed, Embase, Scopus, and the Cochrane Library were searched from inception to May 2026. Methodological quality was evaluated using the Cochrane Risk of Bias tool (RoB 2.0) for randomized controlled trials and the Newcastle-Ottawa Scale (NOS) for cohort and prospective studies. Six studies, totaling 724 patients, were included. The interventions included aerobic, resistance, and multimodal exercise routines. Across studies, physical function (six-minute walk test (6MWT): 395-571 m), muscle strength, and mobility were maintained or enhanced. Fatigue levels improved consistently across validated scales in five studies. All studies found that quality of life increased or remained stable. In one study, exercise was linked to improved treatment tolerance, including appropriate chemotherapy dose intensity and lower neurotoxicity. Adherence (81%-92%) and retention (70%-100%) rates demonstrated high feasibility. Physical activity interventions during and after chemotherapy appear to be practical and effective in improving functional outcomes, fatigue, and quality of life in patients with ovarian cancer. More large-scale trials are required to standardize interventions and validate long-term benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.